{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T10:45:28Z","timestamp":1778150728877,"version":"3.51.4"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1097\/aco.0000000000000696","type":"journal-article","created":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T21:34:52Z","timestamp":1548279292000},"page":"200-205","source":"Crossref","is-referenced-by-count":9,"title":["The use of new procoagulants in blunt and penetrating trauma"],"prefix":"10.1097","volume":"32","author":[{"given":"Maria Rita","family":"Peralta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pratima","family":"Chowdary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-16-20210129","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1136\/emermed-2015-205265","article-title":"The changing face of major trauma in the UK","volume":"32","author":"Kehoe","year":"2015","journal-title":"Emerg Med J"},{"key":"R3-16-20210129","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/01.TA.0000075338.21177.EF","article-title":"Early coagulopathy predicts mortality in trauma","volume":"55","author":"MacLeod","year":"2003","journal-title":"J Trauma"},{"key":"R4-16-20210129","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/jama.2015.12","article-title":"Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial","volume":"313","author":"Holcomb","year":"2015","journal-title":"JAMA"},{"key":"R5-16-20210129","doi-asserted-by":"crossref","first-page":"iii31","DOI":"10.1093\/bja\/aew328","article-title":"Acute traumatic coagulopathy: pathophysiology and resuscitation","volume":"117","author":"Simmons","year":"2016","journal-title":"Br J Anaesth"},{"key":"R6-16-20210129","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/SLA.0b013e318235d9e6","article-title":"Critical role of activated protein C in early coagulopathy and later organ failure, infection and death in trauma patients","volume":"255","author":"Cohen","year":"2012","journal-title":"Ann Surg"},{"key":"R7-16-20210129","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1097\/01.sla.0000256862.79374.31","article-title":"Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway?","volume":"245","author":"Brohi","year":"2007","journal-title":"Ann Surg"},{"key":"R8-16-20210129","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/cvr\/cvq137","article-title":"Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential","volume":"87","author":"Becker","year":"2010","journal-title":"Cardiovasc Res"},{"key":"R9-16-20210129","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/TA.0b013e3181a602a7","article-title":"Coagulopathy by hypothermia and acidosis: mechanisms of thrombin generation and fibrinogen availability","volume":"67","author":"Martini","year":"2009","journal-title":"J Trauma"},{"key":"R10-16-20210129","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/00005373-198208000-00004","article-title":"Major abdominal vascular trauma \u2013 a unified approach","volume":"22","author":"Kashuk","year":"1982","journal-title":"J Trauma"},{"key":"R11-16-20210129","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2141.2004.04868.x","article-title":"Efficacy of standard dose and 30\u200aml\/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients","volume":"125","author":"Chowdary","year":"2004","journal-title":"Br J Haematol"},{"key":"R12-16-20210129","doi-asserted-by":"crossref","first-page":"65S","DOI":"10.1111\/j.1537-2995.2012.03663.x","article-title":"Adverse effects of plasma transfusion","volume":"52","author":"Pandey","year":"2012","journal-title":"Transfusion"},{"key":"R13-16-20210129","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1365-2141.2005.05856.x","article-title":"Guidelines on oral anticoagulation (warfarin): third edition \u2013 2005 update","volume":"132","author":"Baglin","year":"2006","journal-title":"Br J Haematol"},{"key":"R14-16-20210129","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1161\/CIRCULATIONAHA.113.002283","article-title":"Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study","volume":"128","author":"Sarode","year":"2013","journal-title":"Circulation"},{"key":"R16-16-20210129","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1017\/S0265021508004675","article-title":"Prothrombin complex concentrates: a brief review","volume":"25","author":"Samama","year":"2008","journal-title":"Eur J Anaesthesiol"},{"key":"R17-16-20210129","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1055\/s-0038-1655992","article-title":"Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy","volume":"77","author":"Makris","year":"1997","journal-title":"Thromb Haemost"},{"key":"R18-16-20210129","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13054-016-1265-x","article-title":"The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition","volume":"20","author":"Rossaint","year":"2016","journal-title":"Crit Care"},{"key":"R19-16-20210129","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/TA.0b013e318247c944","article-title":"Factor IX complex for the correction of traumatic coagulopathy","volume":"72","author":"Joseph","year":"2012","journal-title":"J Trauma Acute Care Surg"},{"key":"R20-16-20210129","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/TA.0000000000001938","article-title":"The role of four-factor prothrombin complex concentrate in coagulopathy of trauma: a propensity matched analysis","volume":"85","author":"Jehan","year":"2018","journal-title":"J Trauma Acute Surg"},{"key":"R21-16-20210129","doi-asserted-by":"crossref","first-page":"R83","DOI":"10.1186\/cc10078","article-title":"Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy","volume":"15","author":"Schochl","year":"2011","journal-title":"Crit Care"},{"key":"R22-16-20210129","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.injury.2012.08.047","article-title":"The exclusive use of coagulation factor concentrates enables reversal of coagulopathy and decreases transfusion rates in patients with major blunt trauma","volume":"44","author":"Innerhofer","year":"2013","journal-title":"Injury"},{"key":"R23-16-20210129","doi-asserted-by":"crossref","first-page":"e258","DOI":"10.1016\/S2352-3026(17)30077-7","article-title":"Reversal of trauma-induced coagulopathy using first-line coagulation factor concentrates or fresh frozen plasma (RETIC): a single-centre, parallel-group, open-label, randomised trial","volume":"4","author":"Innerhofer","year":"2017","journal-title":"Lancet Haematol"},{"key":"R25-16-20210129","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/ALN.0000000000000608","article-title":"Prothrombin complex concentrates in trauma and perioperative bleeding","volume":"122","author":"Grottke","year":"2015","journal-title":"Anesthesiology"},{"key":"R26-16-20210129","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1097\/TA.0b013e31829e20bf","article-title":"The effects of tranexamic acid and prothrombin complex concentrate on the coagulopathy of trauma: an in vitro analysis of the impact of severe acidosis","volume":"75","author":"Porta","year":"2013","journal-title":"J Trauma Acute Care Surg"},{"key":"R27-16-20210129","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1160\/TH11-02-0101","article-title":"Prothrombin complex concentrate reduces blood loss and enhances thrombin generation in a pig model with blunt liver injury under severe hypothermia","volume":"106","author":"Honickel","year":"2011","journal-title":"Thromb Haemost"},{"key":"R28-16-20210129","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1182\/blood-2011-03-343046","article-title":"Increasing concentrations of prothrombin complex concentrate induce disseminated intravascular coagulation in a pig model of coagulopathy with blunt liver injury","volume":"118","author":"Grottke","year":"2011","journal-title":"Blood"},{"key":"R29-16-20210129","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1538-7836.2011.04211.x","article-title":"Prothrombin complex concentrate and recombinant prothrombin alone or in combination with recombinant factor X and FVIIa in dilutional coagulopathy: a porcine model","volume":"9","author":"Mitterlechner","year":"2011","journal-title":"J Thromb Haemost"},{"key":"R30-16-20210129","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/MBC.0000000000000590","article-title":"Recombinant human prothrombin reduced blood loss in a porcine model of dilutional coagulopathy with uncontrolled bleeding","volume":"28","author":"Hansson","year":"2017","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R31-16-20210129","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1160\/TH11-01-0052","article-title":"Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists. A meta-analysis","volume":"106","author":"Dentali","year":"2011","journal-title":"Thromb Haemost"},{"key":"R32-16-20210129","doi-asserted-by":"crossref","first-page":"R147","DOI":"10.1186\/cc13982","article-title":"Endogenous thrombin potential following hemostatic therapy with 4-factor prothrombin complex concentrate: a 7-day observational study of trauma patients","volume":"18","author":"Sch\u00f6chl","year":"2014","journal-title":"Crit Care"},{"key":"R33-16-20210129","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1073\/pnas.83.8.2412","article-title":"Characterization of a cDNA coding for human factor VII","volume":"83","author":"Hagen","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R34-16-20210129","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/S0140-6736(99)05155-7","article-title":"Treatment of traumatic bleeding with recombinant factor VIIa","volume":"354","author":"Kenet","year":"1999","journal-title":"Lancet"},{"key":"R35-16-20210129","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/01.TA.0000171453.37949.B7","article-title":"Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials","volume":"59","author":"Boffard","year":"2005","journal-title":"J Trauma"},{"key":"R36-16-20210129","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jamcollsurg.2010.08.020","article-title":"Trauma, transfusions, and use of recombinant factor VIIa: a multicenter case registry report of 380 patients from the Western Trauma Association","volume":"212","author":"Knudson","year":"2011","journal-title":"J Am Coll Surg"},{"key":"R37-16-20210129","first-page":"431","article-title":"Recombinant activated factor VII for adjunctive hemorrhage control in trauma","volume":"51","author":"Martinowitz","year":"2001","journal-title":"J Trauma"},{"key":"R38-16-20210129","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/TA.0b013e3181e49059","article-title":"Use of recombinant factor VIIa in US military casualties for a five-year period","volume":"69","author":"Wade","year":"2010","journal-title":"J Trauma"},{"key":"R39-16-20210129","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.thromres.2014.02.026","article-title":"The effects of recombinant activated factor VII dose on the incidence of thromboembolic events in patients with coagulopathic bleeding","volume":"133","author":"Bucklin","year":"2014","journal-title":"Thromb Res"},{"key":"R40-16-20210129","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-154-8-201104190-00004","article-title":"Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications","volume":"154","author":"Yank","year":"2011","journal-title":"Ann Intern Med"},{"key":"R41-16-20210129","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/bjs.10330","article-title":"Combined effect of therapeutic strategies for bleeding injury on early survival, transfusion needs and correction of coagulopathy","volume":"104","author":"Balvers","year":"2017","journal-title":"Br J Surg"},{"key":"R42-16-20210129","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/j.ajem.2018.02.018","article-title":"The effect of fibrinogen concentrate and fresh frozen plasma on the outcome of patients with acute traumatic coagulopathy: a quasi-experimental study","volume":"36","author":"Akbari","year":"2018","journal-title":"Am J Emerg Med"},{"key":"R43-16-20210129","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1177\/1076029617753537","article-title":"Retrospective review of a prothrombin complex concentrate (Beriplex P\/N) for the management of perioperative bleeding unrelated to oral anticoagulation","volume":"24","author":"Chowdary","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"key":"R44-16-20210129","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1001\/archpedi.1978.02120280075016","article-title":"Prothrombin complex concentrates. Use in treatment of hemophiliacs with factor VIII inhibitors","volume":"132","author":"Yolken","year":"1978","journal-title":"Am J Dis Child"},{"key":"R45-16-20210129","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.thromres.2007.02.009","article-title":"Prothrombin complex concentrate (Octaplex) in patients requiring immediate reversal of oral anticoagulation","volume":"121","author":"Riess","year":"2007","journal-title":"Thromb Res"}],"container-title":["Current Opinion in Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00001503-201904000-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T19:42:42Z","timestamp":1611949362000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001503-201904000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/aco.0000000000000696","relation":{},"ISSN":["0952-7907"],"issn-type":[{"value":"0952-7907","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]}}}